Treatment of chronic cervicobrachial pain with periradicular injection of meloxicam

Lucia Aurini, Battista Borghi, Andrea Tognù, Barbara Rossi, Greta Fini, Pierfrancesco Fusco, Massimiliano Mosca, Raffaele Borghi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

BACKGROUND: Cervicobrachial pain (CBP) is often resistant to conventional oral analgesics. We hypothesized that the periradicular injection of meloxicam would produce a significant reduction in their intractable CBP. The secondary objective was to assess the impact of the treatment on functional recovery. METHODS: 48 patients with persistent CBP (>3 months of duration) despite multimodal analgesic therapy received 1-3 periradicular injections of meloxicam, 5-20 mg, at the dermatomal level(s) corresponding to their pain symptoms. Pain level (0=none to 10=severe), rescue analgesics, and functional activity were recorded at baseline and for 90d after the last injection. The injection was repeated if the pain score remained >3 or paresthesia persisted. RESULTS: The mean pain score was reduced from a baseline of 8.9 (±1) to 1.7 (±2.2) at 90 days after the last meloxicam injection. Following meloxicam treatment(s), only 13% of the patients required oral analgesic rescue medication. All patients increased their functional activity level. CONCLUSIONS: Cervical periradicular injection of meloxicam reduced CBP by 81% at 90-day follow-up and also improved functional recovery.

Original languageEnglish
Pages (from-to)411-418
Number of pages8
JournalMinerva Anestesiologica
Volume82
Issue number4
Publication statusPublished - Apr 1 2016

Fingerprint

meloxicam
Chronic Pain
Pain
Injections
Analgesics
Therapeutics
Intractable Pain
Paresthesia

Keywords

  • Meloxicam-Spinal injections-Ultrasonography-Brachial plexus neuritis-Chronic pain.

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Aurini, L., Borghi, B., Tognù, A., Rossi, B., Fini, G., Fusco, P., ... Borghi, R. (2016). Treatment of chronic cervicobrachial pain with periradicular injection of meloxicam. Minerva Anestesiologica, 82(4), 411-418.

Treatment of chronic cervicobrachial pain with periradicular injection of meloxicam. / Aurini, Lucia; Borghi, Battista; Tognù, Andrea; Rossi, Barbara; Fini, Greta; Fusco, Pierfrancesco; Mosca, Massimiliano; Borghi, Raffaele.

In: Minerva Anestesiologica, Vol. 82, No. 4, 01.04.2016, p. 411-418.

Research output: Contribution to journalArticle

Aurini, L, Borghi, B, Tognù, A, Rossi, B, Fini, G, Fusco, P, Mosca, M & Borghi, R 2016, 'Treatment of chronic cervicobrachial pain with periradicular injection of meloxicam', Minerva Anestesiologica, vol. 82, no. 4, pp. 411-418.
Aurini, Lucia ; Borghi, Battista ; Tognù, Andrea ; Rossi, Barbara ; Fini, Greta ; Fusco, Pierfrancesco ; Mosca, Massimiliano ; Borghi, Raffaele. / Treatment of chronic cervicobrachial pain with periradicular injection of meloxicam. In: Minerva Anestesiologica. 2016 ; Vol. 82, No. 4. pp. 411-418.
@article{6afcdafcb0c94e0a8b48dacca3aef962,
title = "Treatment of chronic cervicobrachial pain with periradicular injection of meloxicam",
abstract = "BACKGROUND: Cervicobrachial pain (CBP) is often resistant to conventional oral analgesics. We hypothesized that the periradicular injection of meloxicam would produce a significant reduction in their intractable CBP. The secondary objective was to assess the impact of the treatment on functional recovery. METHODS: 48 patients with persistent CBP (>3 months of duration) despite multimodal analgesic therapy received 1-3 periradicular injections of meloxicam, 5-20 mg, at the dermatomal level(s) corresponding to their pain symptoms. Pain level (0=none to 10=severe), rescue analgesics, and functional activity were recorded at baseline and for 90d after the last injection. The injection was repeated if the pain score remained >3 or paresthesia persisted. RESULTS: The mean pain score was reduced from a baseline of 8.9 (±1) to 1.7 (±2.2) at 90 days after the last meloxicam injection. Following meloxicam treatment(s), only 13{\%} of the patients required oral analgesic rescue medication. All patients increased their functional activity level. CONCLUSIONS: Cervical periradicular injection of meloxicam reduced CBP by 81{\%} at 90-day follow-up and also improved functional recovery.",
keywords = "Meloxicam-Spinal injections-Ultrasonography-Brachial plexus neuritis-Chronic pain.",
author = "Lucia Aurini and Battista Borghi and Andrea Togn{\`u} and Barbara Rossi and Greta Fini and Pierfrancesco Fusco and Massimiliano Mosca and Raffaele Borghi",
year = "2016",
month = "4",
day = "1",
language = "English",
volume = "82",
pages = "411--418",
journal = "Minerva Anestesiologica",
issn = "0375-9393",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "4",

}

TY - JOUR

T1 - Treatment of chronic cervicobrachial pain with periradicular injection of meloxicam

AU - Aurini, Lucia

AU - Borghi, Battista

AU - Tognù, Andrea

AU - Rossi, Barbara

AU - Fini, Greta

AU - Fusco, Pierfrancesco

AU - Mosca, Massimiliano

AU - Borghi, Raffaele

PY - 2016/4/1

Y1 - 2016/4/1

N2 - BACKGROUND: Cervicobrachial pain (CBP) is often resistant to conventional oral analgesics. We hypothesized that the periradicular injection of meloxicam would produce a significant reduction in their intractable CBP. The secondary objective was to assess the impact of the treatment on functional recovery. METHODS: 48 patients with persistent CBP (>3 months of duration) despite multimodal analgesic therapy received 1-3 periradicular injections of meloxicam, 5-20 mg, at the dermatomal level(s) corresponding to their pain symptoms. Pain level (0=none to 10=severe), rescue analgesics, and functional activity were recorded at baseline and for 90d after the last injection. The injection was repeated if the pain score remained >3 or paresthesia persisted. RESULTS: The mean pain score was reduced from a baseline of 8.9 (±1) to 1.7 (±2.2) at 90 days after the last meloxicam injection. Following meloxicam treatment(s), only 13% of the patients required oral analgesic rescue medication. All patients increased their functional activity level. CONCLUSIONS: Cervical periradicular injection of meloxicam reduced CBP by 81% at 90-day follow-up and also improved functional recovery.

AB - BACKGROUND: Cervicobrachial pain (CBP) is often resistant to conventional oral analgesics. We hypothesized that the periradicular injection of meloxicam would produce a significant reduction in their intractable CBP. The secondary objective was to assess the impact of the treatment on functional recovery. METHODS: 48 patients with persistent CBP (>3 months of duration) despite multimodal analgesic therapy received 1-3 periradicular injections of meloxicam, 5-20 mg, at the dermatomal level(s) corresponding to their pain symptoms. Pain level (0=none to 10=severe), rescue analgesics, and functional activity were recorded at baseline and for 90d after the last injection. The injection was repeated if the pain score remained >3 or paresthesia persisted. RESULTS: The mean pain score was reduced from a baseline of 8.9 (±1) to 1.7 (±2.2) at 90 days after the last meloxicam injection. Following meloxicam treatment(s), only 13% of the patients required oral analgesic rescue medication. All patients increased their functional activity level. CONCLUSIONS: Cervical periradicular injection of meloxicam reduced CBP by 81% at 90-day follow-up and also improved functional recovery.

KW - Meloxicam-Spinal injections-Ultrasonography-Brachial plexus neuritis-Chronic pain.

UR - http://www.scopus.com/inward/record.url?scp=84969204412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969204412&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84969204412

VL - 82

SP - 411

EP - 418

JO - Minerva Anestesiologica

JF - Minerva Anestesiologica

SN - 0375-9393

IS - 4

ER -